News | October 27, 2025
Sigachi Industries posts Q2 FY2026 consolidated profit at Rs. 10.68 Cr
Sigachi Industries has reported total income of Rs. 112.97 crore during the period ended September 30, 2025
Sigachi Industries has reported total income of Rs. 112.97 crore during the period ended September 30, 2025
Mesalamine suppositories are indicated for the treatment of mildly to moderately active ulcerative proctitis
Dr Reddys Laboratories has reported total income of Rs. 8,805.1 crore during the period ended September 30, 2025
In the next five years, an additional 75,000 seats are expected to be added across both undergraduate and postgraduate levels
The event will be attended by 35,000+ industry professionals
Agreement adds a new preclinical ADC with potential for enhanced anti-tumour activity and best-in-class profile
Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
Bioconjugation capability to complement commercial payload, linker, and monoclonal antibody services
Efdoralprin Alfa was well tolerated, with a safety profile comparable to plasma-derived therapy
Subscribe To Our Newsletter & Stay Updated
